secwatch.observer — SEC 8-K summary
======================================

Issuer:     CANNAPHARMARX, INC. (CPMD)
CIK:        0001081938
Form:       8-K
Filed at:   2023-06-23T23:59:59+00:00
Accession:  0001683168-23-004371
Event type: leadership
Sentiment:  neutral
Materiality: 0.55
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

CannaPharmaRX appoints Dean Medwid as CEO; Dominic Colvin steps down
--------------------------------------------------------------------

- Dominic Colvin stepped down as CEO effective June 1, 2023; no disagreement over operations.
- Dean Medwid appointed CEO effective June 1, 2023; base salary of CDN $17,325/month plus bonus.
- Medwid has 30+ years experience, previously President of New Leaf Ventures, a cannabis company.
- Colvin will remain with the company providing 'leadership and vision.'
- No family relationships or material interests between Medwid and other officers/directors.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1081938/000168316823004371/0001683168-23-004371-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1081938/000168316823004371/cannapharmarx_8k.htm
  HTML page:      https://secwatch.observer/filing/0001683168-23-004371

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer